The FDA is approving a Pfizer vaccine for seniors that protects them from respiratory syncytial virus, or RSV. On Wednesday, Pfizer said it expects supply to be available within the next few months ahead of the cold and flu season. RSV is a common pathogen that typically causes cold-like symptoms but can be deadly for seniors